MoneyWorks4Me

Syncom Formulations India informs about company updates

24 Nov 2015 Evaluate

Syncom Formulations India has informed that In compliance of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015 the Company has submitted a copy of Policy for Determination of Materiality under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015. Further note that the above said policy was approved by the Board of Directors at their meeting held on November 07, 2015 and shall become applicable with effect from December 01, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..